Performance Evaluation of Artificial Intelligence Screening Model in Coronary Heart Disease Detection

NAActive, not recruitingINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

May 31, 2025

Conditions
Coronary Heart Disease
Interventions
OTHER

Physician readers will be assisted with AI-derived probability and diagnosis of obstructive coronary heart disease

Physician readers will be assisted with AI-derived probability and diagnosis of obstructive coronary heart disease. The AI tool provides individualized obstructive CHD probabilities and diagnosis, leveraging retinal biomarkers associated with cardiovascular risk.

OTHER

Physician readers will be assisted with RF-CL table to calculate the probability of obstructive coronary heart disease

Physicians use a RF-CL table (risk factor weighted clinical likelihood table) to calculate the probability of obstructive CHD.

Trial Locations (3)

100084

Tsinghua University, Beijing

200000

Shanghai Health and Medical Center, Shanghai

Shanghai Sixth People's Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine

UNKNOWN

collaborator

Shanghai Health and Medical Center

UNKNOWN

lead

Tsinghua University

OTHER

NCT06658600 - Performance Evaluation of Artificial Intelligence Screening Model in Coronary Heart Disease Detection | Biotech Hunter | Biotech Hunter